Christopher DeRespino

2021

In 2021, Christopher DeRespino earned a total compensation of $4.3M as Former Chief Business Officer and Interim Chief Financial Officer at Avalanche Biotechnologies.

Compensation breakdown

Bonus$100,000
Option Awards$3,990,495
Salary$211,724
Other$7,889
Total$4,310,108

DeRespino received $4M in option awards, accounting for 93% of the total pay in 2021.

DeRespino also received $100K in bonus, $211.7K in salary and $7.9K in other compensation.

Rankings

In 2021, Christopher DeRespino's compensation ranked 3,080th out of 12,415 executives tracked by ExecPay. In other words, DeRespino earned more than 75.2% of executives.

ClassificationRankingPercentile
All
3,080
out of 12,415
75th
Division
Manufacturing
1,235
out of 5,505
78th
Major group
Chemicals And Allied Products
497
out of 2,375
79th
Industry group
Drugs
439
out of 2,096
79th
Industry
Biological Products, Except Diagnostic Substances
123
out of 449
73rd

Pay ratio

Christopher DeRespino's Pay$4,310,108
Median Employee's Pay$188,229
Pay Ratio

23

to 1

In 2021, the annual total compensation of Christopher DeRespino was $4,310,108.

The annual total compensation of the median employee at Avalanche Biotechnologies was $188,229.

The ratio of Christopher DeRespino's pay to the pay of median employee was therefore 23 to one.

Source: SEC filing on April 26, 2022.

DeRespino's colleagues

We found nine more compensation records of executives who worked with Christopher DeRespino at Avalanche Biotechnologies in 2021.

2021

Laurent Fischer

Avalanche Biotechnologies

Chief Executive Officer

2021

Angela Thedinga

Avalanche Biotechnologies

Chief Technology Officer

2021

Leone Patterson

Avalanche Biotechnologies

Chief Financial Officer

2021

Kishor Soparkar

Avalanche Biotechnologies

Chief Operating Officer

2021

Julie Clark

Avalanche Biotechnologies

Chief Medical Officer

2021

Brigit Riley

Avalanche Biotechnologies

Chief Scientific Officer

2021

Rupert D'Souza

Avalanche Biotechnologies

Chief Financial Officer

2021

Thomas Leung

Avalanche Biotechnologies

Chief Financial Officer

2021

Jack Thrift

Avalanche Biotechnologies

Chief Financial Officer

News

In-depth

You may also like